Allied Market Research published a report, titled, “Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound Care and Therapy Devices), Application (Chronic Wounds, and Acute Wounds) and End User (Hospital, Homecare settings and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global advanced wound care market generated $10.3 billion in 2022, and is anticipated to generate $17.8 billion by 2032, witnessing a CAGR of 5.6% from 2023 to 2032.
Rise in prevalence of Diabetes, obesity, and chronic conditions, technological advancements in wound care management and rise in new product launches for wound care treatment are the factors that drive the growth of the global advanced wound care market. However, stringent regulations for manufacturing of wound care products are expected to restrict the market growth. Moreover, the growth opportunities in emerging markets present new opportunities in the coming years.
Market Statistics
- On the basis of product, the therapy devices segment dominated the market in terms of revenue in 2022.
- On the basis of application, chronic wound segment accounted for largest share in terms of revenue in 2022 and anticipated to witness highest CAGR during the forecast period.
- On the basis of end user, the hospitals segment dominated the market in terms of revenue in 2022. However, the others segment is anticipated to grow at the highest CAGR during the forecast period.
- Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Request Sample of the Report on- https://www.alliedmarketresearch.com/request-sample/903
Factors affecting the growth of the Advanced Wound Care Market:
- The global increase in the elderly population leads to a higher incidence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. This demographic trend significantly drives the demand for advanced wound care products
- The rising prevalence of chronic conditions like diabetes, obesity, and cardiovascular diseases contributes to an increase in chronic wounds, necessitating advanced wound care solutions.
- Innovations in wound care technologies, such as the development of bioactive wound care products (e.g., growth factors, stem cell therapy), smart dressings, and antimicrobial dressings, enhance the effectiveness of treatments and fuel market growth.
- An increase in surgical procedures, particularly those involving extensive post-operative care, boosts the demand for advanced wound care products to manage and prevent surgical site infections.
Economic Downturn Analysis:
- During a recession, individuals and governments tighten their budgets, leading to reduced healthcare spending. Healthcare facilities and providers may thus face budget constraints, compelling suppliers to reduce prices for their products.
- This can affect the profit margins of manufacturers and potentially lead to cost-cutting measures, such as a delay in research and development efforts. As a result, the introduction of new and innovative wound care products could be postponed.
- However, amid a recession, there is a growing emphasis on cost-effective solutions, with healthcare providers and payers seeking evidence-based, affordable wound care options.
Advanced Wound Care Market Segments:
By Product Type:
the therapy devices segment held the largest market share in 2022, accounting for more than one-third of the global advanced wound care market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to rise in number of key players offering advanced therapy devices such as negative pressure wound therapy (NPWT) systems and electrical stimulation devices, rise in regulatory approvals and growing awareness about wound care devices in wound care management.
By Application:
The chronic wound segment held the largest market share in 2022, accounting for than fourth-fifths of the global advanced wound care market revenue and is estimated to register highest CAGR of 5.8% during the forecast period, owing to increase in prevalence chronic wounds such as diabetic foot ulcers and pressure ulcers, rise in aging population and surge in prevalence of chronic diseases such as diabetes and obesity.
By End User:
The hospitals segment accounted for the largest share in 2022, contributing to nearly two-fifths of the global advanced wound care market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to its advanced infrastructure, specialist expertise, inpatient care facilities, wide availability of treatment options for chronic and acute wounds. However, the others segment is expected to witness the fastest CAGR of 6.2% from 2023 to 2032. This is attributed to increase in number of specialty clinics with advanced facilities, trained staff and personalized advanced wound care treatment.
By Region:
North America held the largest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global advanced wound care market revenue and is likely to dominate the market during the forecast period. This growth is attributed to factors such as rise in prevalence of chronic wounds, availability of well-developed healthcare infrastructure such as specialized wound care centers and diabetic clinics and surge in emphasis on early detection and comprehensive management of chronic wounds.
However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.6% from 2023 to 2032. The is attributed to factors such as rise in prevalence of chronic conditions such as diabetes, increase in healthcare expenditure and surge in awareness about the importance of early detection and treatment of wound, is expected to drive the growth of the advanced wound care market.
Leading Market Players
- ConvaTec Group plc.
- Smith and Nephew plc
- 3M Company
- Mölnlycke Health Care AB
- Coloplast
- Organogenesis Holdings Inc.
- Integra LifeSciences Holdings Corporation
- Cardinal Health Inc.
- B. Braun SE
- MIMEDX Group, Inc.
Read More:
Growing at 7.5% CAGR | Clinical Microbiology Market to Reach US$9.7 Billion by 2033
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
